Advanced search
2 files | 3.84 MB Add to list

Development and validation of immunoassays for monitoring of guselkumab and anti-guselkumab antibodies in patients with moderate-to-severe psoriasis

Author
Organization
Project
Keywords
Analytical Chemistry, Spectroscopy, Clinical Biochemistry, Drug Discovery, Pharmaceutical Science, Guselkumab, Psoriasis, Enzyme-linked immunosorbent assay, Immunogenicity, Therapeutic drug monitoring, Monoclonal antibodies, CLINICAL-EFFICACY, TROUGH LEVELS, ADALIMUMAB, INFLIXIMAB, BIOPHARMACEUTICALS, GENERATION

Downloads

  • Van Den Berge N et al accepted manuscript.pdf
    • full text (Accepted manuscript)
    • |
    • open access
    • |
    • PDF
    • |
    • 2.62 MB
  • (...).pdf
    • full text (Published version)
    • |
    • UGent only
    • |
    • PDF
    • |
    • 1.21 MB

Citation

Please use this url to cite or link to this publication:

MLA
Van den Berghe, Nathalie, et al. “Development and Validation of Immunoassays for Monitoring of Guselkumab and Anti-Guselkumab Antibodies in Patients with Moderate-to-Severe Psoriasis.” JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, vol. 189, 2020, doi:10.1016/j.jpba.2020.113433.
APA
Van den Berghe, N., Truffot, A., Peeters, M., Compernolle, G., Brouwers, E., Soenen, R., … Imbrechts, M. (2020). Development and validation of immunoassays for monitoring of guselkumab and anti-guselkumab antibodies in patients with moderate-to-severe psoriasis. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 189. https://doi.org/10.1016/j.jpba.2020.113433
Chicago author-date
Van den Berghe, Nathalie, Aurélie Truffot, Miet Peeters, Griet Compernolle, Els Brouwers, Rani Soenen, Lynda Grine, Ann Gils, and Maya Imbrechts. 2020. “Development and Validation of Immunoassays for Monitoring of Guselkumab and Anti-Guselkumab Antibodies in Patients with Moderate-to-Severe Psoriasis.” JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS 189. https://doi.org/10.1016/j.jpba.2020.113433.
Chicago author-date (all authors)
Van den Berghe, Nathalie, Aurélie Truffot, Miet Peeters, Griet Compernolle, Els Brouwers, Rani Soenen, Lynda Grine, Ann Gils, and Maya Imbrechts. 2020. “Development and Validation of Immunoassays for Monitoring of Guselkumab and Anti-Guselkumab Antibodies in Patients with Moderate-to-Severe Psoriasis.” JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS 189. doi:10.1016/j.jpba.2020.113433.
Vancouver
1.
Van den Berghe N, Truffot A, Peeters M, Compernolle G, Brouwers E, Soenen R, et al. Development and validation of immunoassays for monitoring of guselkumab and anti-guselkumab antibodies in patients with moderate-to-severe psoriasis. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. 2020;189.
IEEE
[1]
N. Van den Berghe et al., “Development and validation of immunoassays for monitoring of guselkumab and anti-guselkumab antibodies in patients with moderate-to-severe psoriasis,” JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, vol. 189, 2020.
@article{8665876,
  articleno    = {{113433}},
  author       = {{Van den Berghe, Nathalie and Truffot, Aurélie and Peeters, Miet and Compernolle, Griet and Brouwers, Els and Soenen, Rani and Grine, Lynda and Gils, Ann and Imbrechts, Maya}},
  issn         = {{0731-7085}},
  journal      = {{JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS}},
  keywords     = {{Analytical Chemistry,Spectroscopy,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Guselkumab,Psoriasis,Enzyme-linked immunosorbent assay,Immunogenicity,Therapeutic drug monitoring,Monoclonal antibodies,CLINICAL-EFFICACY,TROUGH LEVELS,ADALIMUMAB,INFLIXIMAB,BIOPHARMACEUTICALS,GENERATION}},
  language     = {{eng}},
  pages        = {{9}},
  title        = {{Development and validation of immunoassays for monitoring of guselkumab and anti-guselkumab antibodies in patients with moderate-to-severe psoriasis}},
  url          = {{http://doi.org/10.1016/j.jpba.2020.113433}},
  volume       = {{189}},
  year         = {{2020}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: